Effect of a postpartum prescription for pertussis vaccine: a before-and-after study.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 09 11 2020
revised: 23 12 2020
accepted: 27 12 2020
pubmed: 10 1 2021
medline: 29 10 2021
entrez: 9 1 2021
Statut: ppublish

Résumé

Among the strategies to encourage pregnant women to be vaccinated against pertussis in the postpartum period, that of giving them a prescription has been evaluated only sparsely. To measure the effect of giving women who are not immunized against pertussis a prescription for the vaccine at discharge from the maternity unit. Single-center before-and-after study (2011: before; 2015: after). All women received both oral and written information about vaccination against pertussis. During the after period, they were also specifically asked their immunization status during pregnancy. Those currently unimmunized received a written prescription for it at discharge. Among the women unimmunized at delivery, the percentage who were vaccinated postpartum climbed from 17 to 42% between 2011 and 2015 (p < 0.001), while the percentage of their unimmunized partners who were vaccinated remained stable (27 and 29%, p = 0.74). During this time, the percentage of women immunized against pertussis at the beginning of pregnancy rose from 32 to 52% (p < 0.001). Finally, the percentage of all women protected against this disease postpartum climbed from 44 to 72% between these two periods (p < 0.001). In the postpartum period, giving a prescription for pertussis vaccine to women unimmunized is accompanied by a significant elevation in their vaccination rate. Nevertheless, this rate remains low and better strategies have to be implemented.

Sections du résumé

BACKGROUND BACKGROUND
Among the strategies to encourage pregnant women to be vaccinated against pertussis in the postpartum period, that of giving them a prescription has been evaluated only sparsely.
OBJECTIVE OBJECTIVE
To measure the effect of giving women who are not immunized against pertussis a prescription for the vaccine at discharge from the maternity unit.
MATERIAL AND METHODS METHODS
Single-center before-and-after study (2011: before; 2015: after). All women received both oral and written information about vaccination against pertussis. During the after period, they were also specifically asked their immunization status during pregnancy. Those currently unimmunized received a written prescription for it at discharge.
RESULTS RESULTS
Among the women unimmunized at delivery, the percentage who were vaccinated postpartum climbed from 17 to 42% between 2011 and 2015 (p < 0.001), while the percentage of their unimmunized partners who were vaccinated remained stable (27 and 29%, p = 0.74). During this time, the percentage of women immunized against pertussis at the beginning of pregnancy rose from 32 to 52% (p < 0.001). Finally, the percentage of all women protected against this disease postpartum climbed from 44 to 72% between these two periods (p < 0.001).
CONCLUSIONS CONCLUSIONS
In the postpartum period, giving a prescription for pertussis vaccine to women unimmunized is accompanied by a significant elevation in their vaccination rate. Nevertheless, this rate remains low and better strategies have to be implemented.

Identifiants

pubmed: 33421623
pii: S2468-7847(20)30426-8
doi: 10.1016/j.jogoh.2020.102050
pii:
doi:

Substances chimiques

Pertussis Vaccine 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

102050

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Marion Bucchiotty (M)

Univ. Lille, CHU Lille, Hôpital Jeanne de Flandre, F-59000 Lille, France. Electronic address: marion_jb_10@hotmail.fr.

Saliha El Morabit (S)

Univ. Lille, CHU Lille, Hôpital Jeanne de Flandre, F-59000 Lille, France.

Yamina Hammou (Y)

Univ. Lille, CHU Lille, Hôpital Jeanne de Flandre, F-59000 Lille, France.

Rachida Gallouj (R)

Univ. Lille, CHU Lille, Hôpital Jeanne de Flandre, F-59000 Lille, France.

Nasser Messaadi (N)

Univ. Lille, Département de Médecine Générale, F-59000 Lille, France.

Sophie Vanderstichele (S)

Univ. Lille, CHU Lille, Hôpital Jeanne de Flandre, F-59000 Lille, France.

Marielle Roumilhac (M)

Univ. Lille, CHU Lille, Hôpital Jeanne de Flandre, F-59000 Lille, France.

Philippe Dufour (P)

Univ. Lille, CHU Lille, Hôpital Jeanne de Flandre, F-59000 Lille, France.

Damien Subtil (D)

Univ. Lille, CHU Lille, Hôpital Jeanne de Flandre, F-59000 Lille, France; Univ. Lille, EA 2694 Santé Publique, Épidémiologie et Qualité des Soins, F-59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH